Healthcare Services Market Size to Worth USD 20.10 Trillion by 2035, Amid Rising Digital Healthcare Adoption – SNS Insider

The global healthcare services market is projected to grow from USD 8.62 trillion in 2025 to USD 20.10 trillion by 2035, with a CAGR of 8.87%. Growth is driven by rising chronic disease prevalence, aging populations, and digital healthcare adoption including telehealth and AI-enabled care. The U.S. market is expected to reach USD 4.93 trillion and Europe USD 6.25 trillion by 2035. Hospital services will dominate with 44% market share, while telehealth services will experience the fastest growth.

06/20/2026, 4:27 AM • GlobeNewswire

Insider Sells $71,000 Worth of Telehealth Stock, According to Latest SEC Filing

Fernando M. Rodrigues, President of BetterHelp, completely divested his 9,572 shares of Teladoc Health (valued at ~$71,000) in a June 3, 2026 transaction. This represents a 100% exit of his direct holdings. Teladoc continues to struggle with profitability despite beating revenue expectations, posting a $171 million net loss over the trailing twelve months, though the stock has stabilized with only a 3% decline over the past year.

06/08/2026, 10:30 AM • The Motley Fool

Are These Beaten-Down Stocks Generational Opportunities or Value Traps?

Two pandemic-era winners, Teladoc Health and PayPal, have both declined over 80% in the past five years. Teladoc faces insurmountable headwinds from competition and unprofitability, making it a value trap to avoid. PayPal, however, maintains strong brand recognition, network effects, and growth opportunities in digital advertising, positioning it as a potential generational buying opportunity at current levels.

04/27/2026, 8:30 PM • The Motley Fool

Online Therapy Services Market Projected to Surpass USD 17.34 Billion by 2035, Driven by Rising Mental Health Awareness and Expanding Telehealth Platforms – SNS Insider

The global online therapy services market is valued at USD 4.38 billion in 2025 and is expected to reach USD 17.34 billion by 2035, growing at a CAGR of 14.76%. Growth is driven by rising mental health awareness, expanding telehealth adoption, and AI-enabled mental health tools. However, data privacy concerns and limited digital access in some regions may hinder expansion. North America leads with 40.12% market share, while Asia Pacific shows the fastest growth at 20.71% CAGR.

03/06/2026, 5:59 AM • GlobeNewswire

Emotional Counseling Service Market Report 2026-2035: A $21.21 Billion Industry by 2030 with Cleveland Clinic, Teladoc Health., LifeStance, GoodRx, Thriveworks, Headspace, Lyra Health, MDLive Leading

The emotional counseling service market is projected to grow from $4.72 billion in 2025 to $21.21 billion by 2030, with a CAGR of 35%. Growth drivers include increased digital therapy adoption, rising mental health infrastructure investments, employer-sponsored services expansion, and focus on adolescent mental health. Leading companies are leveraging AI-based tools and tele-counseling platforms to enhance accessibility and personalized care.

02/23/2026, 4:51 AM • GlobeNewswire

Is Teladoc Stock Going to $0 -- or Ready for a Comeback?

Teladoc Health has lost 98% of its market value over five years as telemedicine demand normalized post-pandemic. Despite efforts to expand internationally, launch new services, and secure insurance coverage for BetterHelp, the company faces intense competition from larger corporations, slow revenue growth, and negative earnings. The analyst believes the stock is more likely to continue declining toward $0 rather than stage a meaningful recovery.

02/22/2026, 5:33 AM • The Motley Fool

Tele-Monitoring Services: Growing at 18% CAGR, Bringing Health Closer to Families

The global tele-monitoring services market is valued at USD 36.59 billion in 2026 and is expected to reach USD 164.55 billion by 2035, growing at an 18.18% CAGR. North America leads the market while Asia Pacific shows the fastest growth. Remote patient monitoring dominates by service type, with wearables and mobile devices driving device segment growth. Key drivers include rising chronic disease prevalence, aging populations, and technological advancements in IoT and AI.

02/19/2026, 10:00 AM • GlobeNewswire

Stock Market Today, Feb. 9: Hims & Hers Health Drops 16% on Novo Nordisk Lawsuit

Hims & Hers Health stock plummeted 16% on February 9, 2026, following a lawsuit from Novo Nordisk and FDA regulatory crackdown on compounded GLP-1 drugs. The company had announced it would withdraw its copycat obesity drug amid regulatory pressure. The stock has fallen 26.89% over five days as investors weigh legal and regulatory risks.

02/09/2026, 6:34 PM • The Motley Fool

Stock Market Today, Feb. 9: Hims & Hers Health Drops 16% on Novo Nordisk Lawsuit

Hims & Hers Health stock plummeted 16% on February 9, 2026, following a lawsuit from Novo Nordisk and FDA regulatory crackdown on compounded GLP-1 drugs. The company had withdrawn its copycat obesity drug amid regulatory pressure. The broader market gained modestly, with the S&P 500 up 0.47% and Nasdaq up 0.90%.

02/09/2026, 5:30 PM • The Motley Fool

Once Medicare Stops Covering Telehealth Services, Will Teladoc Health Stock be in Trouble?

Medicare will end broad telehealth coverage starting January 31, 2026, limiting it mainly to rural areas. However, Teladoc Health's revenue is primarily derived from commercial customers like employers and health plans rather than Medicare, suggesting the policy change may not significantly impact the company. Despite this, Teladoc faces ongoing challenges including competition, declining mental health revenue, and failure to achieve profitability.

01/28/2026, 4:10 PM • The Motley Fool

2 Beaten-Down Stocks That Could Sink Even More in 2026

Sarepta Therapeutics and Teladoc Health are identified as two stocks likely to continue declining in 2026. Sarepta faces significant headwinds from safety concerns with its flagship DMD treatment Elevidys, which caused patient deaths and led to restricted access. Teladoc Health struggles with slowing revenue growth, mounting losses, and increased competition in the telemedicine space, particularly affecting its BetterHelp platform.

01/21/2026, 10:30 PM • The Motley Fool

Teladoc Health Launches Enhanced 24/7 Care Service

Teladoc Health announced enhancements to its 24/7 Care virtual urgent care service, expanding treatment capabilities to include a broader range of conditions, enabling specialist consultations during visits, improving preventive care detection, and allowing real-time prescription benefit checks. The service now reaches over 100 million Americans and demonstrates high member satisfaction with 95% of concerns addressed in single visits.

01/12/2026, 6:00 AM • GlobeNewswire

Dialectical Behavior Therapy Market Set to Surge at 9.67% CAGR by 2034, Rising Adoption and Technological Advancements

The global dialectical behavior therapy market is projected to grow from USD 1.31 billion in 2025 to USD 3.29 billion by 2034, driven by rising mental health awareness, technological advancements, and expanding digital therapy platforms.

11/12/2025, 11:00 AM • GlobeNewswire

Is This Beaten-Down Stock Finally on the Road to Recovery?

Teladoc Health continues to struggle with declining revenue and profitability challenges, despite potential growth opportunities in mental health services and international expansion. The stock remains unattractive to investors due to competitive landscape and uncertain growth prospects.

11/03/2025, 9:24 PM • The Motley Fool

Better Beaten-Down Stock: Iovance Biotherapeutics vs. Teladoc Health

The article compares two healthcare companies, Iovance Biotherapeutics and Teladoc Health, as potential contrarian investment opportunities. While both companies face challenges, the analysis suggests Teladoc is currently the more attractive option due to its established ecosystem and lower risk profile.

10/17/2025, 6:17 AM • The Motley Fool